Post Profile

Related Posts

AstraZeneca - Faslodex, NICE say no

Medical / Pharmaceutical : PharmaGossip

LONDON -(Dow Jones)- AstraZeneca PLC's (AZN) breast cancer drug Faslodex doesn't represent value for money and consequently shouldn't be made available on the U.K.'s publicly funded National Health Service, according to the country'...

New Ovarian Cancer Treatment Approved In US

US Politics / Liberal : Alan Colmes' Liberaland

(Reuters) – AstraZeneca Plc’s ovarian cancer drug has been granted an accelerated approval by the U.S. health regulator, a day after the treatment was approved by the European Commission. An advisory panel to the U.S. Food and Drug ...

AstraZeneca Fails to Gain U.S. Approval for Its Rival to Plavix - BusinessWeek

Medical / Pharmaceutical : PharmaGossip

Dec. 17 (Bloomberg) -- AstraZeneca Plc failed to win U.S. approval for a new blood thinner to rival Plavix, the world’s second-best selling drug. The Food and Drug Administration asked for additional analysis of a study called Plato...

AstraZeneca pulls cancer drug application in Europe

Health : Reuters: Health

LONDON (Reuters) - AstraZeneca has pulled an application seeking European approval to sell its experimental cancer drug cediranib in combination with chemotherapy to treat ovarian cancer because of late-stage questions raised by reg...

UK cost body NICE rules against AstraZeneca's breast cancer drug Faslodex | Reuters

Medical / Pharmaceutical : PharmaGossip

Nov 10 (Reuters) - AstraZeneca's breast cancer drug Faslodex has been rejected for use on Britain's state health service, dealing a blow to a product that has been on the market in Europe since 2004. The National Institute for Healt...


Copyright © 2016 Regator, LLC